Min S. Chang

1.7k total citations
40 papers, 1.4k citations indexed

About

Min S. Chang is a scholar working on Molecular Biology, Immunology and Pharmacology. According to data from OpenAlex, Min S. Chang has authored 40 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Immunology and 8 papers in Pharmacology. Recurrent topics in Min S. Chang's work include Pesticide Residue Analysis and Safety (5 papers), Cancer-related molecular mechanisms research (5 papers) and Barrier Structure and Function Studies (5 papers). Min S. Chang is often cited by papers focused on Pesticide Residue Analysis and Safety (5 papers), Cancer-related molecular mechanisms research (5 papers) and Barrier Structure and Function Studies (5 papers). Min S. Chang collaborates with scholars based in United States, United Kingdom and China. Min S. Chang's co-authors include Alan Brash, William E. Boeglin, Frederick R. Haselton, Tawakol A. El‐Shourbagy, David M. Bader, W. Todd Monroe, J. Steven Alexander, Jun Zhang, George C.Y. Chiou and Qin Ji and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Min S. Chang

39 papers receiving 1.4k citations

Peers

Countries citing papers authored by Min S. Chang

Since Specialization

Citations

This map shows the geographic impact of Min S. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min S. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min S. Chang more than expected).

Fields of papers citing papers by Min S. Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min S. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min S. Chang. The network helps show where Min S. Chang may publish in the future.

Co-authorship network of co-authors of Min S. Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Min S. Chang. A scholar is included among the top collaborators of Min S. Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min S. Chang. Min S. Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	“Zhibian (BL54) to Shuidao (ST28)” Acupuncture Manipulation Combined with Analgesics in Postoperative Pain Management for Patients with Mixed Hemorrhoids: A Randomized Controlled Trial Protocol 2025 ·Journal of Pain Research ·(unknown), (unknown), Min S. Chang, (unknown), (unknown), (unknown), (unknown), (unknown), Hai-Jun Wang, Yu Cao	0
2	BVES regulates EMT in human corneal and colon cancer cells and is silenced via promoter methylation in human colorectal carcinoma 2011 ·Journal of Clinical Investigation ·Christopher S. Williams, Baolin Zhang, J. Joshua Smith, Ashwath Jayagopal, Caitlyn W. Barrett, Christopher J. Pino, Patricia K. Russ, (unknown), Dunfa Peng, (unknown), Frederick R. Haselton, (unknown), M. Kay Washington, Xi Chen, Steven A. Eschrich, Timothy J. Yeatman, Wael El‐Rifai, R. Daniel Beauchamp, Min S. Chang	61
3	Bves Modulates Tight Junction Associated Signaling 2011 ·PLoS ONE ·Patricia K. Russ, Christopher J. Pino, Christopher S. Williams, David M. Bader, Frederick R. Haselton, Min S. Chang	37
4	Preparation and cytotoxic activity of hydroxycamptothecin nanosuspensions 2010 ·International Journal of Pharmaceutics ·Yongxing Zhao, (unknown), Haiying Hua, Min S. Chang, Weijing Liu, (unknown), (unknown), Hong‐Min Liu	48
5	Identification of a Novel Intracellular Interaction Domain Essential for Bves Function 2008 ·PLoS ONE ·Michiya Kawaguchi, (unknown), Aya Wada, Tatsuki Koyama, Min S. Chang, David M. Bader	30
6	Accurate determination of an immunosuppressant in stented swine tissues with LC–MS/MS 2007 ·Analytical and Bioanalytical Chemistry ·Jun Zhang, (unknown), Qin Ji, Min S. Chang, Tawakol A. El‐Shourbagy, Sandra L. Burke, Lewis B. Schwartz	6
7	Evaluation of 384‐well formatted sample preparation technologies for regulated bioanalysis 2006 ·Rapid Communications in Mass Spectrometry ·Min S. Chang, (unknown), Tawakol A. El‐Shourbagy	11
8	A novel approach for in‐process monitoring and managing cross‐contamination in a high‐throughput high‐performance liquid chromatography assay with tandem mass spectrometric detection 2006 ·Rapid Communications in Mass Spectrometry ·Min S. Chang, (unknown), Tawakol A. El‐Shourbagy	11
9	Automated 96-well liquid–liquid back extraction liquid chromatography–tandem mass spectrometry method for the determination of ABT-202 in human plasma 2004 ·Journal of Pharmaceutical and Biomedical Analysis ·Naxing Xu, (unknown), (unknown), (unknown), (unknown), Min S. Chang, Tawakol A. El‐Shourbagy	20
10	Method development for the concentration determination of a protein in human plasma utilizing 96‐well solid‐phase extraction and liquid chromatography/tandem mass spectrometric detection 2003 ·Rapid Communications in Mass Spectrometry ·Qin Ji, (unknown), (unknown), Min S. Chang, Tawakol A. El‐Shourbagy	22
11	Reduced expression of the adherens junction protein cadherin-5 in a diabetic retina 2000 ·American Journal of Ophthalmology ·Mari K. Davidson, Patricia K. Russ, Gloria G. Glick, Loren H. Hoffman, Min S. Chang, Frederick R. Haselton	32
12	Targeting Expression with Light Using Caged DNA 1999 ·Journal of Biological Chemistry ·W. Todd Monroe, (unknown), Min S. Chang, J. Steven Alexander, Frederick R. Haselton	142
13	Investigation of a Second 15S-Lipoxygenase in Humans and its Expression in Epithelial Tissues 1999 ·Advances in experimental medicine and biology ·Alan Brash, Mitsuo Jisaka, William E. Boeglin, Min S. Chang, Diane S. Keeney, Lillian B. Nanney, Siegfried Kasper, Robert J. Matusik, Sandra J. Olson, Scott B. Shappell	19
14	Molecular Cloning of a Second Human 15S-Lipoxygenase and its Murine Homologue, an 8S-Lipoxygenase 1999 ·Advances in experimental medicine and biology ·Alan Brash, Mitsuo Jisaka, William E. Boeglin, Min S. Chang	19
15	Dose-proportional pharmacokinetics of a new 5-lipoxygenase inhibitor, ABT-761, in healthy volunteers 1998 ·Biopharmaceutics & Drug Disposition ·Shekman Wong, Jeffrey Drajesk, Min S. Chang, Galen Witt, Walid M. Awni	4
16	Induction of rabbit cyclooxygenase 2 in the anterior uvea following glaucoma filtration surgery 1997 ·Current Eye Research ·Min S. Chang, James C. Tsai, Rong Yang, Raymond N. DuBois, Matthew D. Breyer, Denis M. O’Day	7
17	Prevention and Treatment of Ocular Inflammation with a New Class of Non-Steroidal Anti-Inflammatory Agents 1994 ·Journal of Ocular Pharmacology and Therapeutics ·George C.Y. Chiou, Quansheng Yao, Min S. Chang, Tadashi Okawara	16
18	Systemic Delivery of Insulin through Eyes to Lower the Glucose Concentration 1989 ·Journal of Ocular Pharmacology and Therapeutics ·George C.Y. Chiou, (unknown), Min S. Chang	23
19	Prevention of Lens Protein-Induced Ocular Inflammation with Cyclooxygenase and Lipoxygenase Inhibitors 1989 ·Journal of Ocular Pharmacology and Therapeutics ·Min S. Chang, George C.Y. Chiou	12
20	Systematic delivery of enkephalin peptide through eyes 1988 ·Life Sciences ·George C.Y. Chiou, (unknown), Min S. Chang	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact